Showing results (61-70 of 89) with videos related to
Sort By:
Pageof 9
Hepatology International|September 28, 2019
Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosisQianyi Wang, Hong You, Xiaojuan Ou, et al.Scientific Reports|February 16, 2018
Quantitative assessment of liver fibrosis (qFibrosis) reveals precise outcomes in Ishak "stable" patients on anti-HBV therapyYameng Sun, Jialing Zhou, Xiaoning Wu, et al.Hepatology International|August 16, 2024
Delicate and thin fibrous septa indicate a regression tendency in metabolic dysfunction-associated steatohepatitis patients with advanced fibrosisXiaofei Tong, Yameng Sun, Qianyi Wang, et al.Journal of Medical Virology|October 12, 2023
Persistent steatosis correlates with decreased fibrosis regression during anti-HBV treatment in patients with chronic HBV infectionMengyang Zhang, Shuyan Chen, Xiaoning Wu, et al.Clinical and Molecular Hepatology|May 11, 2023
Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patientsXiaoning Wu, Xiaoqian Xu, Jialing Zhou, et al.Hepatology International|August 19, 2023
Distinct on-treatment HCC risks associated with different decompensation events in HBV patients with cirrhosisYuanyuan Kong, Yameng Sun, Xiaoning Wu, et al.JCI Insight|October 29, 2020
microRNA-483 ameliorates hypercholesterolemia by inhibiting PCSK9 productionJianjie Dong, Ming He, Jie Li, et al.Theranostics|April 11, 2025
Hepatic stellate cell-derived microfibrillar-associated protein 2 prevents liver fibrosis by regulating extracellular matrix and inflammationWen Zhang, Wenyue Wu, Ning Zhang, et al.Infection and Drug Resistance|April 25, 2019
Entecavir monotherapy versus de novo combination of lamivudine and adefovir for compensated hepatitis B virus-related cirrhosis: a real-world prospective multicenter cohort studyXiaoning Wu, Jialing Zhou, Wen Xie, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 10, 2020
Persistent Low Level of Hepatitis B Virus Promotes Fibrosis Progression During TherapyYameng Sun, Xiaoning Wu, Jialing Zhou, et al.Pageof 9